Briefs Filed In Patent Dispute Over Plans For Generic Nasal Spray

Mealey's (November 1, 2017, 7:44 AM EDT) -- WASHINGTON, D.C. — The Federal Circuit U.S. Court of Appeals was recently briefed on a case that poses the question of whether prior art taught away from the use of the compound zolmitriptan for nasal administration, as was found by a Delaware federal judge (Impax Laboratories Inc., et al., v. Lannett Holdings Inc., No. 17-2020, Fed. Cir.)....